152 related articles for article (PubMed ID: 12624005)
1. Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1.
Egashira K
Hypertension; 2003 Mar; 41(3 Pt 2):834-41. PubMed ID: 12624005
[TBL] [Abstract][Full Text] [Related]
2. Stress and vascular responses: anti-inflammatory therapeutic strategy against atherosclerosis and restenosis after coronary intervention.
Kitamoto S; Egashira K; Takeshita A
J Pharmacol Sci; 2003 Mar; 91(3):192-6. PubMed ID: 12686741
[TBL] [Abstract][Full Text] [Related]
3. Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases.
Kitamoto S; Egashira K
Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):393-400. PubMed ID: 15030267
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy targeting monocyte chemoattractant protein-1 for vascular disease.
Kitamoto S; Egashira K
J Atheroscler Thromb; 2002; 9(6):261-5. PubMed ID: 12560586
[TBL] [Abstract][Full Text] [Related]
5. Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits.
Mori E; Komori K; Yamaoka T; Tanii M; Kataoka C; Takeshita A; Usui M; Egashira K; Sugimachi K
Circulation; 2002 Jun; 105(24):2905-10. PubMed ID: 12070121
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory gene therapy for cardiovascular disease.
Matoba T; Egashira K
Curr Gene Ther; 2011 Dec; 11(6):442-6. PubMed ID: 22023473
[TBL] [Abstract][Full Text] [Related]
7. Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys.
Ohtani K; Usui M; Nakano K; Kohjimoto Y; Kitajima S; Hirouchi Y; Li XH; Kitamoto S; Takeshita A; Egashira K
Gene Ther; 2004 Aug; 11(16):1273-82. PubMed ID: 15175640
[TBL] [Abstract][Full Text] [Related]
8. Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys.
Usui M; Egashira K; Ohtani K; Kataoka C; Ishibashi M; Hiasa K; Katoh M; Zhao Q; Kitamoto S; Takeshita A
FASEB J; 2002 Nov; 16(13):1838-40. PubMed ID: 12223446
[TBL] [Abstract][Full Text] [Related]
9. Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation.
Tatewaki H; Egashira K; Kimura S; Nishida T; Morita S; Tominaga R
J Vasc Surg; 2007 Jun; 45(6):1236-43. PubMed ID: 17543688
[TBL] [Abstract][Full Text] [Related]
10. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice.
Inoue S; Egashira K; Ni W; Kitamoto S; Usui M; Otani K; Ishibashi M; Hiasa K; Nishida K; Takeshita A
Circulation; 2002 Nov; 106(21):2700-6. PubMed ID: 12438296
[TBL] [Abstract][Full Text] [Related]
11. Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice.
Ni W; Kitamoto S; Ishibashi M; Usui M; Inoue S; Hiasa K; Zhao Q; Nishida K; Takeshita A; Egashira K
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):534-9. PubMed ID: 14739122
[TBL] [Abstract][Full Text] [Related]
12. Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis.
Egashira K; Koyanagi M; Kitamoto S; Ni W; Kataoka C; Morishita R; Kaneda Y; Akiyama C; Nishida KI; Sueishi K; Takeshita A
FASEB J; 2000 Oct; 14(13):1974-8. PubMed ID: 11023981
[TBL] [Abstract][Full Text] [Related]
13. Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in cynomolgus monkeys.
Nakano K; Egashira K; Ohtani K; Zhao G; Funakoshi K; Ihara Y; Sunagawa K
Atherosclerosis; 2007 Oct; 194(2):309-16. PubMed ID: 17126840
[TBL] [Abstract][Full Text] [Related]
14. Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels.
Zhong L; Chen WQ; Ji XP; Zhang M; Zhao YX; Yao GH; Zhang PF; Zhang C; Zhang Y
J Cell Mol Med; 2008 Dec; 12(6A):2362-71. PubMed ID: 18266972
[TBL] [Abstract][Full Text] [Related]
15. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice.
Ni W; Egashira K; Kitamoto S; Kataoka C; Koyanagi M; Inoue S; Imaizumi K; Akiyama C; Nishida KI; Takeshita A
Circulation; 2001 Apr; 103(16):2096-101. PubMed ID: 11319201
[TBL] [Abstract][Full Text] [Related]
16. Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys.
Egashira K; Zhao Q; Kataoka C; Ohtani K; Usui M; Charo IF; Nishida K; Inoue S; Katoh M; Ichiki T; Takeshita A
Circ Res; 2002 Jun; 90(11):1167-72. PubMed ID: 12065319
[TBL] [Abstract][Full Text] [Related]
17. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys.
Egashira K; Nakano K; Ohtani K; Funakoshi K; Zhao G; Ihara Y; Koga J; Kimura S; Tominaga R; Sunagawa K
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2563-8. PubMed ID: 17885211
[TBL] [Abstract][Full Text] [Related]
18. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
[TBL] [Abstract][Full Text] [Related]
19. Transfection with a dominant-negative inhibitor of monocyte chemoattractant protein-1 gene improves cardiac function after 6 hours of cold preservation.
Kajihara N; Morita S; Nishida T; Tatewaki H; Eto M; Egashira K; Yasui H
Circulation; 2003 Sep; 108 Suppl 1():II213-8. PubMed ID: 12970235
[TBL] [Abstract][Full Text] [Related]
20. Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia.
Namiki M; Kawashima S; Yamashita T; Ozaki M; Hirase T; Ishida T; Inoue N; Hirata K; Matsukawa A; Morishita R; Kaneda Y; Yokoyama M
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):115-20. PubMed ID: 11788470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
